Maintenance Therapy

Maintenance therapy isn’t generally used in AML. However, if you have a particular type of AML, known as acute promyelocytic leukaemia (APL), you may be offered further treatment. 

If your leukaemia has responded well to treatment with ATRA, an oral drug that is similar to vitamin A, you may benefit from further treatment with the same drug for 1 to 2 years following your initial treatment.

Maintenance therapy is given over the longer term to help ensure that any leukaemia cells present following induction and consolidation therapy are destroyed, in order to minimise the risk of relapse. 

 

Videos

Na czym polega leczenie podtrzymujace?

Dr Agnieszka Wierzbowska z Uniwersytetu Medycznego w Lodzi tlumaczy, na czym polega leczenie podtrzymujace. Jest to podawanie nisko dawkowanej chemioterapii w celu zapobieganiu nawrotom choroby.

Published:

El tratamiento de mantenimiento

La doctora Anna Sureda, Jefa del Servicio de Hematología del Hospital Duran i Reynals (Instituto Catalán de Oncología), nos explica qué es el tratamiento de mantenimiento en la leucemia aguda. El objetivo es que el paciente permanezca en remisión completa.

Published:

La terapia di mantenimento

La dott.ssa Chiara Bonini, docente all’Università Vita-Salute San Raffaele di Milano (IT), al Congresso Annuale dell’ASH (American Society of Hematology) del 2016 spiega l’efficacia della terapia di mantenimento. Questa terapia utilizzata solo in alcuni tumori del sangue ha l’obiettivo, dopo la terapia di induzione e di consolidamento, di mantenere lo stato di benessere e remissione completa a lungo termine.

Published:

Terapia de manutenção em leucemias agudas

Dr. Eduardo Rego da Universidade de São Paulo, São Paulo, Brasil, descreve a terapia de manutencão. Esta fase do tratamento tem como objectivo garantir que quaisquer células residuais sejam elimnadas.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on April 3, 2017